Data / Form D filings / Revere Pharmaceuticals Inc.
Revere Pharmaceuticals Inc.: Form D filings
Revere Pharmaceuticals Inc., a pharmaceuticals company in Arlington, MA, filed 5 Form D notices with the SEC between 2019 and 2023. The latest, on June 12, 2023, reports $1.6 million sold of a $3.6 million offering to 22 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 36 ORVIS ROAD, Arlington, MA, 02474
- Phone
- (781) 718-9033
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1778959
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 12, 2023 | New notice | $3,559,612 | $1,622,604 | $1,937,008 | 22 | Jun 1, 2023 | sec.gov |
| Sep 1, 2021 | New notice | $1,999,999 | $1,056,199 | $943,800 | 30 | Aug 27, 2021 | sec.gov |
| Jan 12, 2021 | Amendment | $3,454,842 | $3,454,842 | 61 | Jun 11, 2019 | sec.gov | |
| Jun 22, 2020 | Amendment | $3,487,668 | $1,587,363 | $1,900,305 | 30 | Jun 11, 2019 | sec.gov |
| Jun 21, 2019 | New notice | $1,923,915 | $1,212,374 | $711,541 | 20 | Jun 11, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kollol Robert Pal | Director | |
| Marc Robert Lippman | Director | |
| Ian Robert Silverman | Executive Officer, Director | |
| Jedd Robert Levine | Executive Officer, Director |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Jun 12, 2023 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Revere Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.